Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.25 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
1.10 1.40 1.25 1.25 1.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2.26 -0.98 -0.17 9
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 1.25 GBX

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Investors    Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
30/1/202323:39Deltex Medical - a British success story!11,805
20/12/202216:20Deltex Medical - winner or doomed to fail? 421
07/4/202214:50Deltex Medical-Optimal Growth Stock10,017
22/3/201209:04Deltex Medical - Past, Present and Future-
07/12/201111:57Deltex Medical - More key endorsements-

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-02-02 10:08:571.1718,631217.05O
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Top Posts
Posted at 03/2/2023 08:20 by Deltex Medical Daily Update
Deltex Medical Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 1.25p.
Deltex Medical Group Plc has a 4 week average price of 1.25p and a 12 week average price of 0.75p.
The 1 year high share price is 1.40p while the 1 year low share price is currently 0.75p.
There are currently 699,063,796 shares in issue and the average daily traded volume is 49,327 shares. The market capitalisation of Deltex Medical Group Plc is £8,738,297.45.
Posted at 25/1/2023 08:00 by gbenson1
So true amt, I too have been "invested" in DEMG from day one, perhaps one day we might see a little return, I just wish we could get out to a wider audience. I agree with some it's about time for a change at the top, we need to be more dynamic..
Posted at 16/1/2023 14:06 by gbenson1
It's all gone quiet again just like prior to the TU, DEMG should be promoting their new monitor more rigorously and shouting from the roof tops, I know their trying to minimise spend but we need more promoting of our industry approved and accepted products. Think its gonna take news on the new monitor release and the sales opportunity mentioned in the TU to CPR the Sp back to life!! Hoping for a RNS very shortly..
Posted at 11/1/2023 15:23 by dj trading
Director remuneration in 2021 was 19.5% of turnover!!!! 2022?!!!
How do they justify that?

CEO £216k
FDs £102k (changed in May 21)
Non Execs £122k (£17k cash and £105k equity)
Total £440k on turnover of just £2.26m!!!

Share option awards
2020 4,000,000 ex price 1.325p
2021 5,000,000 es price 1.8p
2022 15,000,000 ex price 1.35p

2022 8,500,000 ex price 1.35p

Note share price has fallen 95% in the past 10 years from 25p to 1.2p ish

Posted at 10/1/2023 09:08 by mrc2u
>>dogloverOK. Let me try to address what I think your points might be.Do I have £250,000? No. If I did, would I put it into DEMG? No, I would not put any more in while Keen is chair. If I had £250k and there were a new chair, I would put it in as equity not debt. Debt is toxic in small loss making companies and DEMG can not afford the interest.MrC
Posted at 09/1/2023 11:25 by doglover2003

If I wasn't persistent I would have dropped DEMG many years ago.

But you are non being consistent by saying that you:

* would not lend to DEMG unsecured ( whilst Nigel is Chair)

* Nigel taking £100k back in interest is excessive

If the company needs the funding ( and you will not provide it) where is it to come from?

The Company needs continuing funding for now at least.

Anyway, what magic wand do you think a new Chairperson could wave?

The mistake that the company did make was NOT to take it Private when the opportunity was there.

Posted at 08/1/2023 20:02 by doglover2003
mrC2u, thanks for your reply.

Let's take this step by step.

You confirm that you would not have provided a loan as Nigel has done.
As for your reason relating to Nigel's leadership I don't think that has a bearing on on the matter that we are discussing.

The question you have to ask is why was Nigel himself prepared to make this facility available at this point of time when you would not have. I would also admit that I also would not have been prepared to make such a loan.

I am sure you will agree with me that no one other than Nigel understands where the company stands at present better having shephered the company since its incorporation, I believe.

I do not think that it a stretch to conclude that Nigel will have a pretty good idea whether Trueview is going to make sufficient difference to warrant this demonstration of support.

If you think about it how many shares could he have purchased with £250k if there had been a placing alongside a prospectus laying out the company's current position and forecast etc.

If you agree that this is a make or break time for the company compare the outcomes for Nigel between a Placing and this loan:


High upside from rise in share price.
Downside 100 % loss of investment


Upside limited to same rate of growth in share price but for a lower investment
Downside 100 % loss of investment including Loan

Essentially, the same financial commitment would not justify the loan unless the company could limp on to cover repayments of the new loan as well as the existing £500k.

My conclusion is that Nigel wants to demonstrate his continued belief in the company and expectation that Trueview will deliver.

If I am wrong about this then perhaps both he and I are fools.

Posted at 08/1/2023 16:15 by mrc2u
>>dogloverWell, I certainly wouldn't lend it to DEMG while Keen is still chair. Has he been chair for 33 or 34 years now?I am sure he doesn't want his career to end with DEMG going bust, but surely he would do better financially to bring in a fresh chair, thin down and refresh the Board and all that.MrC
Posted at 07/1/2023 08:49 by doglover2003
I have not posted on DEMG for a long time.

However, I have been mulling over how the news that Nigel Keen has provided an additional of £250,000 to the £500,000 unsecured Standby loan at 8 per cent relating to the imminent launch of the new Truevue Monitor.

At this stage in the proceedings I wonder why he has been willing to provide this further facility.

Clearly, this must be the make or break time for the company. If Truevue is not adopted to a significant extent DEMG has no future and will fold. Conversely, if Truevue is taken up to a significant extent this will give a new lease of life to the company.

It is worth noting the the company Imperialise Ltd providing the facilty has net assets of around £200k according to the March 2022 accounts. I think one can conclude that at this time providing finance for Deltex would appear to be either its main or sole activity.

At this pivotal time there is little doubt that trading in DEMG shares by Nigel Keen would be forbidden under insider trading rules as Nigel Keen will know better than anyone else what are the immediate trading prospects for DEMG from the launch.

So, how do we interpret this facility from Nigel? If he believed the impact on trade prospects from the launch to be poor to moderate would he really add to his investment in DEMG with no real prospect of success? I think not. Further, if he held doubts about the success of the launch at this modest level would he throw good money after bad with virtually no prospect of recovering the principal if the markets took a negative view?

Nigel remains the largest individual investor in the company apart from institutional investors. Would he really throw away a further £250k without a good prospect of improved fortunes for the company?

Being unable to buy shares at this time he has helped the company the best way he can and we should all be grateful for that. The recent price movements suggest that others see it that way too.

Posted at 18/5/2022 16:45 by schloo

Seriously? Is that pathetic distortion the best you have got?

1. I'm not going to pay to read an editorial just because of some troll, but the thrust of the piece is obviously supportive of what DEMG have been trying to achieve for years
2. Of course the evidence for goal directed fluid optimisation remains contested. Otherwise it would be enforced as a standard of care across the world
3. There is only one author on this paper, Prof Henrik Kehlet. Spoke to him earlier this year and he categorically does not contest the evidence for goal directed fluid optimisation guided by DEMG's Doppler technologies. He is just very frustrated that so many people can't be bothered with evidence based best practice
4. As highlighted by the Count there are lots of studies with the Edwards & Lidco technologies but they simply can not deliver the same results as DEMG's Doppler. Perhaps that is because they measure completely different things in different ways in different places
5. Conflating PPWA with Doppler has caused confusion, whether due to lack of intellectual rigour or bias or industry affiliation related bias. Fluid optimisation during surgery is highly effective with Doppler but not with PPWA
6. However the choices remain stark: make Doppler happen or carry on wasting lives and money

No idea why you are so anti-DEMG. No idea how you live with yourself for tolerating routine delivery of second rate & harmful care

DEMG have not been able to change your mind, nor has probably the most robust evidence base for any anaesthetic protocol/intervention anywhere ever, nor the myriad of experts who have wasted years trying to lead their colleagues to improve care. This is why DEMG need to sell to a major who can persuade with marketing where medical science has failed

Hope you are still young enough to see the light at a ski 'meeting' or some such activity generously supported with an 'unrestricted educational grant' from DEMG's next owners

Posted at 02/11/2020 07:32 by nobbygnome
Yes should be good news for DEMG share price as it will show the true value of a business like this!
Deltex Medical share price data is direct from the London Stock Exchange
Your Recent History
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230203 10:22:27